Hysteroscopy Devices Market By Product Type (Hysteroscopes [Rigid Hysteroscopes And Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments And Disposable Instruments), By Application (Diagnostic Hysteroscopy And Operative Hysteroscopy [Myomectomy, Polypectomy, Endometrial Ablation, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, And Others), by geography, is anticipated to expand at a noteworthy CAGR forecast till 2027 due to the growing prevalence of gynaecological disorders and rising adoption rate of minimally invasive surgeries.
The global hysteroscopy devices market was valued at USD 1.29 billion in 2021, growing at a CAGR of 7.40% during the forecast period from 2021 to 2027, to reach USD 2.13 billion by 2027. The increase in demand for hysteroscopy devices is predominantly attributed to the rising geriatric women population across the globe coupled with growing cases of gynecological disorders. In addition, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are some of the key factors which is expected to drive the growth of the global hysteroscopy devices market.
The market for hysteroscopy devices is gaining momentum at present owing to the rise in gynecological disorders among women across the globe. As per the World Health Organization (WHO) 2021 data, Endometriosis, a disease where tissue similar to the lining of the uterus grows outside the uterus affects roughly 10% (190 million) of reproductive age women and girls globally.
Moreover, according to the GLOBOCAN 2020 statistics, a total of 9,227,484 new cancer cases were reported among females, worldwide in the year 2020, out of which 6.5% or 604,127 were suffering from cervix uteri cancer.
In addition, the escalating burden of the women population tending towards old age is also another factor that could surge the market for hysteroscopy devices in the upcoming years. This is because old women are more susceptible to developing various gynecological disorders such as genital prolapse, postmenopausal bleeding, and others. For instance, according to the World Population Ageing 2020 highlights, there were approximately 727 million population aged 65 years or over, worldwide and women accounted for about 55% of the global population aged 65 years or over.
Furthermore, rising product approval of various advanced hysteroscopy devices is also anticipated to spike the market for hysteroscopy devices during the forecasted period. For instance, in July 2020, Karl Storz SE & Co. KG received FDA clearance for its Endomat Select, a hysteroscopy insufflator to provide the infusion of the sterile irrigant solutions into the ureter and upper urinary tract, and others.
Also, in January 2020, LiNA Medical ApS received FDA approval for LiNA OperaScope, a hysteroscope intended for use in the visualization of the cervical canal and uterine cavity during diagnostic and therapeutic gynecological procedures.
Thus, all the above-mentioned factors are expected to surge the global market for hysteroscopy devices during the forecasted period.
However, the risk of infection from hysteroscopes and stringent regulatory approval process for hysteroscopy devices is likely to impede the hysteroscopy devices market.
Further, the market for hysteroscopy devices witnessed slow growth during the COVID-19 pandemic. This is because the pandemic has caused a global health emergency, enforcing social distancing and preserving hospital resources for the management of the outbreak thus suspending nonessential medical visits. In addition, halt in elective surgical procedures during the pandemic, implementation of stringent guidelines by the national governments across the globe to curb the transmission of the infection also slowed down the hysteroscopy devices market. However, the launch of various vaccines and mass vaccination drives will help in regaining normalcy to the hysteroscopy market during the post-pandemic period.
Hysteroscopy Devices Market By Product Type (Hysteroscopes [Rigid Hysteroscopes and Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments and Disposable Instruments), By Application (Diagnostic Hysteroscopy and Operative Hysteroscopy [Myomectomy, Polypectomy, Endometrial Ablation, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Hysteroscopy Devices product segment, the hysteroscopes segment which is further subcategorized into rigid and flexible hysteroscopes is expected to hold a significant market share in the forthcoming years. The flexible hysteroscope is preferred over rigid hysteroscope due to various advantages associated with it. For instance, flexible hysteroscopes with smaller diameters have shown some advantages over standard rigid hysteroscopes in some studies. They are less invasive because there is no requirement for the dilation of the cervix or tendons. Thus, these features are associated with less pain.
Moreover, the latest flexible hysteroscopy equipment has been significantly improved. New fiber optics, video systems, cameras, and lighting have improved the quality of the systems.
For instance, in March 2019, Hologic received a CE mark for its Omni hysteroscope, a three-in-one modular scope with visualization capabilities designed for both diagnostic and therapeutic hysteroscopy procedures. The reusable rod lens of the hysteroscope utilizes rod lenses for visualization and fibers for illumination.
Hence, all the aforementioned factors are projected to contribute to the segmental growth of the global hysteroscopy devices market in the upcoming years.
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forthcoming years. This domination is owing to the increasing concern of gynecological and reproductive health problems among the women in the region. In addition, the rise in hysteroscopy procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the rise in awareness about women's health, among others are also expected to bolster the market for hysteroscopy devices.
For instance, in the US, according to the American Cancer Society 2021 statistics, approximately 66,750 new cases of uterine/endometrial cancer are expected to be diagnosed in the same year.
In addition, as per the Office of the Assistant Secretary for Health (OASH) 2019 data, more than 11% of American women between 15 and 44 age were suffering from endometriosis in the same year.
Furthermore, an increase in hysteroscopy procedures in the country will also contribute to the market growth of hysteroscopy devices. For instance, as per the data revealed by the Center for Menstrual Disorders 2021, in the year 2017, there were over 500,000 hysteroscopic endometrial ablations performed in the United States per year. The center has performed nearly 3500 major operative hysteroscopy procedures till January 2018.
Moreover, the presence of key manufacturers in the region such as Medtronic, Hologic, CooperSurgical, and Stryker, among others, and various product approvals belonging to hysteroscopy procedures are anticipated to spike the market for hysteroscopy devices in the region. For instance, recently on September 25, 2020, Stryker received FDA clearance for various versions of Reprocessed MyoSure Tissue Removal Devices to hysteroscopically resect and remove tissue such as submucous myomas, endometrial polyps, and retained products of conception.
Thus, all the above-stated factors are expected to propel the hysteroscopy devices market in the region.
Further, the Asia-pacific region has future potential for the hysteroscopy devices market. The increasing old-age female population is the key driving factor. For instance, according to the United Nations Population Fund 2021 statistics, the number of older people in the Asia-Pacific will triple reaching 1.3 billion by 2050 where women constitute the majority (53%) of the population aged 60 or older in the region. It is also estimated that their share will rise to 60% for ages above 80 years. Additionally, the rising burden of gynecological disorders, presence of regional as well as global leaders active in manufacturing hysteroscopy devices such as Olympus and Advin Health Care, among others in the region is likely to contribute to the market growth during the forecasted period.
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
Hysteroscopy is a procedure that allows a healthcare professional to look inside the uterus to diagnose and treat the causes of various gynecological disorders. The medical devices used during the procedure are in general known as hysteroscopy devices and mainly include hysteroscopes, hysteroscopy fluid management systems, hysteroscopy dilators, and others.
2. What is the market for Global Hysteroscopy Devices?
The global hysteroscopy devices market was valued at USD 1.29 billion in 2021, growing at a CAGR of 7.40% during the forecast period from 2021 to 2027, to reach USD 2.13 billion by 2027.
3. What are the drivers for the Global Hysteroscopy Devices?
The major factors driving the demand for Hysteroscopy Devices are the growing geriatric women population across the globe coupled with growing cases of gynecological disorders. Furthermore, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are also expected to drive the growth of the global hysteroscopic devices market.
4. What are the key players operating in Global Hysteroscopy Devices?
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
5. Which region has the highest share in the Hysteroscopy Devices market?
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forecasted period, 2022-2027. This domination is owing to the rapidly increasing concern of gynecological and reproductive health problems among the female in the region. Also, the rise in hysteroscopic procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the growing awareness about women's health, among others are expected to bolster the market for hysteroscopic devices.
This product will be delivered within 2 business days.
The global hysteroscopy devices market was valued at USD 1.29 billion in 2021, growing at a CAGR of 7.40% during the forecast period from 2021 to 2027, to reach USD 2.13 billion by 2027. The increase in demand for hysteroscopy devices is predominantly attributed to the rising geriatric women population across the globe coupled with growing cases of gynecological disorders. In addition, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are some of the key factors which is expected to drive the growth of the global hysteroscopy devices market.
Hysteroscopy Devices Market Dynamics:
The market for hysteroscopy devices is gaining momentum at present owing to the rise in gynecological disorders among women across the globe. As per the World Health Organization (WHO) 2021 data, Endometriosis, a disease where tissue similar to the lining of the uterus grows outside the uterus affects roughly 10% (190 million) of reproductive age women and girls globally.
Moreover, according to the GLOBOCAN 2020 statistics, a total of 9,227,484 new cancer cases were reported among females, worldwide in the year 2020, out of which 6.5% or 604,127 were suffering from cervix uteri cancer.
In addition, the escalating burden of the women population tending towards old age is also another factor that could surge the market for hysteroscopy devices in the upcoming years. This is because old women are more susceptible to developing various gynecological disorders such as genital prolapse, postmenopausal bleeding, and others. For instance, according to the World Population Ageing 2020 highlights, there were approximately 727 million population aged 65 years or over, worldwide and women accounted for about 55% of the global population aged 65 years or over.
Furthermore, rising product approval of various advanced hysteroscopy devices is also anticipated to spike the market for hysteroscopy devices during the forecasted period. For instance, in July 2020, Karl Storz SE & Co. KG received FDA clearance for its Endomat Select, a hysteroscopy insufflator to provide the infusion of the sterile irrigant solutions into the ureter and upper urinary tract, and others.
Also, in January 2020, LiNA Medical ApS received FDA approval for LiNA OperaScope, a hysteroscope intended for use in the visualization of the cervical canal and uterine cavity during diagnostic and therapeutic gynecological procedures.
Thus, all the above-mentioned factors are expected to surge the global market for hysteroscopy devices during the forecasted period.
However, the risk of infection from hysteroscopes and stringent regulatory approval process for hysteroscopy devices is likely to impede the hysteroscopy devices market.
Further, the market for hysteroscopy devices witnessed slow growth during the COVID-19 pandemic. This is because the pandemic has caused a global health emergency, enforcing social distancing and preserving hospital resources for the management of the outbreak thus suspending nonessential medical visits. In addition, halt in elective surgical procedures during the pandemic, implementation of stringent guidelines by the national governments across the globe to curb the transmission of the infection also slowed down the hysteroscopy devices market. However, the launch of various vaccines and mass vaccination drives will help in regaining normalcy to the hysteroscopy market during the post-pandemic period.
Hysteroscopy Devices Market Segment Analysis:
Hysteroscopy Devices Market By Product Type (Hysteroscopes [Rigid Hysteroscopes and Flexible Hysteroscopes], Hand-Held Instruments [Forceps, Scissors, Dilators, Others], Hysteroscopic Fluid Management Systems, Hysteroscopic Tissue Removal Systems, Hystero-Resectoscopes, Others), By Usability (Reusable Instruments and Disposable Instruments), By Application (Diagnostic Hysteroscopy and Operative Hysteroscopy [Myomectomy, Polypectomy, Endometrial Ablation, Others]), By End-User (Hospitals, Ambulatory Surgical Centers, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Hysteroscopy Devices product segment, the hysteroscopes segment which is further subcategorized into rigid and flexible hysteroscopes is expected to hold a significant market share in the forthcoming years. The flexible hysteroscope is preferred over rigid hysteroscope due to various advantages associated with it. For instance, flexible hysteroscopes with smaller diameters have shown some advantages over standard rigid hysteroscopes in some studies. They are less invasive because there is no requirement for the dilation of the cervix or tendons. Thus, these features are associated with less pain.
Moreover, the latest flexible hysteroscopy equipment has been significantly improved. New fiber optics, video systems, cameras, and lighting have improved the quality of the systems.
For instance, in March 2019, Hologic received a CE mark for its Omni hysteroscope, a three-in-one modular scope with visualization capabilities designed for both diagnostic and therapeutic hysteroscopy procedures. The reusable rod lens of the hysteroscope utilizes rod lenses for visualization and fibers for illumination.
Hence, all the aforementioned factors are projected to contribute to the segmental growth of the global hysteroscopy devices market in the upcoming years.
North America is expected to dominate the Overall Hysteroscopy Devices Market:
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forthcoming years. This domination is owing to the increasing concern of gynecological and reproductive health problems among the women in the region. In addition, the rise in hysteroscopy procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the rise in awareness about women's health, among others are also expected to bolster the market for hysteroscopy devices.
For instance, in the US, according to the American Cancer Society 2021 statistics, approximately 66,750 new cases of uterine/endometrial cancer are expected to be diagnosed in the same year.
In addition, as per the Office of the Assistant Secretary for Health (OASH) 2019 data, more than 11% of American women between 15 and 44 age were suffering from endometriosis in the same year.
Furthermore, an increase in hysteroscopy procedures in the country will also contribute to the market growth of hysteroscopy devices. For instance, as per the data revealed by the Center for Menstrual Disorders 2021, in the year 2017, there were over 500,000 hysteroscopic endometrial ablations performed in the United States per year. The center has performed nearly 3500 major operative hysteroscopy procedures till January 2018.
Moreover, the presence of key manufacturers in the region such as Medtronic, Hologic, CooperSurgical, and Stryker, among others, and various product approvals belonging to hysteroscopy procedures are anticipated to spike the market for hysteroscopy devices in the region. For instance, recently on September 25, 2020, Stryker received FDA clearance for various versions of Reprocessed MyoSure Tissue Removal Devices to hysteroscopically resect and remove tissue such as submucous myomas, endometrial polyps, and retained products of conception.
Thus, all the above-stated factors are expected to propel the hysteroscopy devices market in the region.
Further, the Asia-pacific region has future potential for the hysteroscopy devices market. The increasing old-age female population is the key driving factor. For instance, according to the United Nations Population Fund 2021 statistics, the number of older people in the Asia-Pacific will triple reaching 1.3 billion by 2050 where women constitute the majority (53%) of the population aged 60 or older in the region. It is also estimated that their share will rise to 60% for ages above 80 years. Additionally, the rising burden of gynecological disorders, presence of regional as well as global leaders active in manufacturing hysteroscopy devices such as Olympus and Advin Health Care, among others in the region is likely to contribute to the market growth during the forecasted period.
Hysteroscopy Devices Market Key Players:
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
Recent Developmental Activities in the Hysteroscopy Devices Market:
- In October 2021, Hologic launched its expanded gynecological surgical offering, Omni suite, in Europe, Africa, and the Middle East (EMEA). The expanded offering currently includes a versatile Omni 30° hysteroscope, the Omni Lok cervical seal, and the Omni 5 French seal.
- In January 2021, Hologic launched Fluent® Fluid Management System for hysteroscopic procedures in Europe.
- In May 2020, Olympus signed an exclusive agreement with UVision360, Inc. to distribute the LUMINELLE® DTx Hysteroscopy System in the U.S.
Key Takeaways from the Hysteroscopy Devices Market Report Study
- Market size analysis for current market size (2021), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Hysteroscopy Devices market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the Global Hysteroscopy Devices Market.
- Various opportunities available for the other competitor in the Hysteroscopy Devices Market space.
- What are the top-performing segments in 2021? How these segments will perform in 2027.
- Which are the top-performing regions and countries in the current market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for Hysteroscopy Devices market growth in the coming future?
Target Audience who can be benefited from the Hysteroscopy Devices Market Report Study
- Hysteroscopy Devices providers
- Research organizations and consulting companies
- Hysteroscopy Devices-related organization, association, forum, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders in Hysteroscopy Devices
- Various End-users who want to know more about the Hysteroscopy Devices Market and latest technological developments in the Hysteroscopy Devices market.
- Frequently Asked Questions for the Hysteroscopy Devices Market:
Hysteroscopy is a procedure that allows a healthcare professional to look inside the uterus to diagnose and treat the causes of various gynecological disorders. The medical devices used during the procedure are in general known as hysteroscopy devices and mainly include hysteroscopes, hysteroscopy fluid management systems, hysteroscopy dilators, and others.
2. What is the market for Global Hysteroscopy Devices?
The global hysteroscopy devices market was valued at USD 1.29 billion in 2021, growing at a CAGR of 7.40% during the forecast period from 2021 to 2027, to reach USD 2.13 billion by 2027.
3. What are the drivers for the Global Hysteroscopy Devices?
The major factors driving the demand for Hysteroscopy Devices are the growing geriatric women population across the globe coupled with growing cases of gynecological disorders. Furthermore, shifting preferences towards minimally invasive surgeries, technological advancements in the product arena, and rising product approvals, among others, are also expected to drive the growth of the global hysteroscopic devices market.
4. What are the key players operating in Global Hysteroscopy Devices?
Some of the key market players operating in the Hysteroscopy Devices market include Medtronic, Olympus, Stryker, Hologic, Boston Scientific Corporation, KARL STORZ, Richard Wolf GmbH., Advin Health Care, Ethicon (Johnson & Johnson), MEDGYN PRODUCTS, INC., CooperSurgical Inc., Cook, Maxer Endoscopy GmbH, Meditrina, Inc., XION, EMOS Technology GmbH, LUMINELLE® (UVision360), LiNA Medical ApS, RUDOLF Medical GmbH + Co. KG, Ackermann, among others.
5. Which region has the highest share in the Hysteroscopy Devices market?
Among all the regions, North America is expected to occupy a major share in the overall Hysteroscopy Devices market during the forecasted period, 2022-2027. This domination is owing to the rapidly increasing concern of gynecological and reproductive health problems among the female in the region. Also, the rise in hysteroscopic procedures in the region, the presence of well-established reimbursement policies for hysteroscopy, and the growing awareness about women's health, among others are expected to bolster the market for hysteroscopic devices.
This product will be delivered within 2 business days.
Table of Contents
1. Hysteroscopy Devices Market Report Introduction6. COVID-19 Impact Analysis on Hysteroscopy Devices Market8. Hysteroscopy Devices Global Company Share Analysis - Key 3-5 Companies10. KOL Views11. Project Approach12. About the Publisher13. Disclaimer & Contact the Publisher
2. Hysteroscopy Devices Market Executive summary
3. Regulatory and Patent Analysis
4. Hysteroscopy Devices Market Key factors analysis
5. Hysteroscopy Devices Porter's Five Forces Analysis
7. Hysteroscopy Devices Market layout
9. Hysteroscopy Devices Company and Product Profiles
List of Tables
List of Figures
